Hain Lifescience is a manufacturer and supplier of molecular biological test systems. The company was originally founded as a mail-order business only; its current focus changed to independent design, production and sales of state of the art diagnostic systems.
The Hain Lifescience assays are based on the innovative DNA•Strip® technology, a robust and reliable method for routine diagnostics of disease-associated polymorphisms, microbiological species differentiation and resistance determination. All tests can be readily combined with each other, and a minimum of equipment is needed. Therefore, large as well as small labs can generate rapid, safe and efficient results. Depending on the required sample throughput, all DNA•Strip® technology based tests can be performed manually or may be integrated into an automated routine workflow.

Dental diagnostics is another main focus of Hain Lifescience. The product range includes the micro-IDent® test for the determination of periodontopathogenic marker pathogens and the GenoType® PST® test for the determination of the genetic risk developing of periodontitis, making Hain Lifescience to a worldwide market leader. These most recent molecular genetic analytical systems allow the implementation of an individual and consequently a maximum successful periodontitis therapy.


Company history:

·    2006 building of an additional office and manufacturing facility in Nehren
·    Since 2001 development of an international distribution network. Currently          located in Europe, the USA, Australia / New Zealand, South Africa,                    Taiwan/China and the Middle East
·    2001 renaming to Hain Lifescience GmbH
·    2000 completion of a second office and manufacturing building in Nehren
·    1997 development of the DNA•Strip® technology
·    1995 establishment of a nationwide sales force for individual customer care
·    1986 year of foundation of Hain Diagnostika

Focuses:

·   Microbiological diagnostics
    o   Mycobacteria
    o   Resistant infectious agents
    o   Chlamydia
    o   Human papilloma virus (HPV)
·   Human genetic diagnostics
    o   Blood coagulation / thrombophilia
    o   Risk determination for hereditary diseases
·   Dental diagnostics
    o   Periodontopathogenic marker species determination
    o   Determination of genetic risk for periodontitis
    o   Caries diagnostics
·   Pancreas function diagnostics
·   Sampling and sample transport
    o   Smear systems
    o   Shipping systems

Milestones:

2005
·    GenoType® LCT for the determination of the genetic risk of developing                  primary lactose intolerance
·    GenoType® MRSA Direct for the detection of MRSA directly from smears          without the need to grow cultures
·    GenoType® Staphylococcus for the identification of various staphylococci          species from cultures
2004
·    Start of distribution of the PreTect® HPV-Proofer from Norchip in Germany;          diagnosis of human papilloma viruses
·    micro-IDent®plus for extended periodontitis diagnostics
·    GenoType® MTBDR for the detection of the most relevant genetically based      resistances to rifampicin/isoniazide of the M. tuberculosis complex
·    GenoType® Mycobacteria Direct for the direct detection of the M.                        tuberculosis complex and four common mycobacteria other than tuberculosis      (MOTT)
·    Extension of the GenoType® Mycobacterium test by introduction of                      GenoType® Mycobacterium CM and GenoType® Mycobacterium AS
2002-2003
·    Launch of more DNA•Strip® technology based tests
    o   GenoType® MTBC
    o   GenoType® EHEC
    o   GenoType® Enterococcus
    o   ThromboType® plus
    o   GenoType® PAI 1
    o   GenoType® ApoE
2001
·    Launch of the mycobacterial product range featuring GenoType®                          Mycobacterium for the culture differentiation of the M. tuberculosis complex          and common MOTT
·    GenoType® MRSA for the detection of MRSA from cultures
2000
·    Launch of GenoType® HH for the detection of hereditary hemochromatosis          and GenoType® AAT for the detection of alpha-1-antitrypsin deficiency
1999
·    Start of distribution of Pankreas-Elastase-ELISA from Bioserv Diagnostics in      Germany
·    Extension of the thrombophilia panel by GenoType® MTHFR
·    GenoType® PST® for the risk determination of parodontopathies
1998
·    Launch of ThromboType® for the detection of the factor V Leiden and                  prothrombin G20210A mutations
1997
·    Distribution of SeroCT™ und SeroCP™ for the detection of antibodies against      Chlamydia trachomatis and Chlamydia pneumoniae
1996
·    micro-IDent® for the detection of parodontopathogenic marker pathogens in          periodontal pockets